Evidence map›Paper›PMID 23525186›Full record

ArticleInternational journal of clinical rheumatology2012

Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Mario García-Carrasco, Claudia Mendoza-Pinto, César Jiménez-Hernández, Mario Jiménez-Hernández, Arnulfo Nava-Zavala, Carlos Riebeling

Abstract read
In one paragraph

Article in International journal of clinical rheumatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mario García-CarrascoSystemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR IMSS, 10 Poniente 2721, Puebla, Mexico ; Department of Rheumatology, School of Medicine, BUAP, Mexico.
Claudia Mendoza-Pinto
César Jiménez-Hernández
Mario Jiménez-Hernández
Arnulfo Nava-Zavala
Carlos Riebeling
Mexican Social Security Institute · MXCentro Medico Nacional Siglo XXI · MX

Funding

SJOGRENS SYNDROME SALIVARY GLAND AND APOPTOSISR01DE012203 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DANG, HOWARD · 1999 to 2001
$453k
NIDCR NIH HHS R01 DE012203
6 · The paper itself

Abstract

Sjögren's syndrome (SS) is a chronic inflammatory systemic autoimmune disease. The disease spectrum extends from sicca syndrome to systemic involvement and extraglandular manifestations, and SS may be associated with malignancies, especially non-Hodgkin's lymphoma. Patients with SS present a broad spectrum of serologic features. Certain serological findings are highly correlated with specific clinical features, and can be used as prognostic markers.

Indexed as

clinical featureshematologic abnormalitieslymphomaprognosisserologic findingsSjögren’s syndrome

Identifiers

PMID23525186
PMCPMC3602968
OpenAlexW2126742402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.